Asgard Alcobev Ltd · BSE: 512025 · Alcoholic Beverages · price as of the 20 November 2026 close, updated every trading day · results updated weekly
Asgard Alcobev share price today: ₹35.39 at the BSE close on 20 November 2026, down 28.3% in a year. Asgard Alcobev (BSE: 512025) is worth ₹1,104 crore, trades at a P/E of 294.9 and has closed between ₹28.37 and ₹56.51 over the past 52 weeks. Latest change: number of shareholders up 254% in a year.
Asgard Alcobev Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer.
The main question: promoters moved −11.1 percentage points over 8 quarters while the business went the other way.
The price has been falling for 62 weeks, and the P/E is lower than 55% of its own last 1 year. Over the last four quarters, results have been improving, with profit +1,394.1% on a year earlier, and 67% of the last 2 years' profit came in as cash. What will decide it: whether the owners’ moves turn back in line with the business.
Figures we could not check: Some figures on this page come from a second data source that we could not check against the main one, because the two do not cover enough of the same periods. They are shown because they are the only figures there are, and every section that uses one is marked unverified.
What is the Asgard Alcobev share price today?
Asgard Alcobev Ltd's share price was ₹35.39 at the close on 20 November 2026. It has been falling for 62 weeks. That is 5.1% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹28 and ₹57, and at that close it sat 25% of the way up from that low.
A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Asgard Alcobev Ltd is in stage 4. The phase helps read everything below.
Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 4 weeks in a row.
Week by week since 2022: did it beat the NIFTY 500 over the past 13 weeks?
Ahead in 56 of 128 weeks
| Week | 13-week return vs NIFTY 500 |
|---|---|
| 23 Dec 2022 | no NIFTY 500 reading |
| 30 Dec 2022 | no NIFTY 500 reading |
| 6 Jan 2023 | no NIFTY 500 reading |
| 13 Jan 2023 | no NIFTY 500 reading |
| 23 Jan 2023 | no NIFTY 500 reading |
| 30 Jan 2023 | no NIFTY 500 reading |
| 13 Feb 2023 | no NIFTY 500 reading |
| 27 Feb 2023 | no NIFTY 500 reading |
| 6 Mar 2023 | no NIFTY 500 reading |
| 21 Mar 2023 | no NIFTY 500 reading |
| 29 Mar 2023 | no NIFTY 500 reading |
| 30 Jun 2023 | no NIFTY 500 reading |
| 3 Jul 2023 | no NIFTY 500 reading |
| 14 Jul 2023 | +70.7% |
| 21 Dec 2023 | +13.5% |
| 19 Jul 2024 | −25.8% |
| 25 Jul 2024 | −39.4% |
| 1 Aug 2024 | −27.8% |
| 9 Aug 2024 | −3.4% |
| 14 Aug 2024 | +12.6% |
| 22 Aug 2024 | +42.2% |
| 30 Aug 2024 | +69.5% |
| 6 Sep 2024 | +68.2% |
| 13 Sep 2024 | +110.6% |
| 19 Sep 2024 | +138.8% |
| 27 Sep 2024 | +142.6% |
| 3 Oct 2024 | +152.5% |
| 11 Oct 2024 | +207.3% |
| 15 Oct 2024 | +210.8% |
| 21 Oct 2024 | +175.6% |
| 8 Nov 2024 | +146.3% |
| 21 Nov 2024 | +117.8% |
| 29 Nov 2024 | +138.4% |
| 6 Dec 2024 | +135.1% |
| 13 Dec 2024 | +127.3% |
| 20 Dec 2024 | +113.7% |
| 27 Dec 2024 | +101.9% |
| 3 Jan 2025 | +99.3% |
| 10 Jan 2025 | +90.0% |
| 17 Jan 2025 | +97.6% |
| 24 Jan 2025 | +84.5% |
| 1 Feb 2025 | +76.7% |
| 7 Feb 2025 | +73.1% |
| 14 Feb 2025 | +71.3% |
| 21 Feb 2025 | +66.1% |
| 28 Feb 2025 | +41.9% |
| 7 Mar 2025 | +25.6% |
| 13 Mar 2025 | +22.7% |
| 21 Mar 2025 | +16.0% |
| 28 Mar 2025 | +16.0% |
| 4 Apr 2025 | +9.3% |
| 11 Apr 2025 | +4.9% |
| 17 Apr 2025 | −13.1% |
| 25 Apr 2025 | −9.2% |
| 2 May 2025 | −6.2% |
| 9 May 2025 | −8.2% |
| 16 May 2025 | −14.2% |
| 23 May 2025 | −15.6% |
| 30 May 2025 | −17.1% |
| 6 Jun 2025 | −23.2% |
| 13 Jun 2025 | −24.7% |
| 20 Jun 2025 | −20.5% |
| 27 Jun 2025 | −16.5% |
| 4 Jul 2025 | −15.7% |
| 11 Jul 2025 | −7.7% |
| 18 Jul 2025 | +1.1% |
| 25 Jul 2025 | −8.3% |
| 1 Aug 2025 | −15.7% |
| 8 Aug 2025 | −26.4% |
| 14 Aug 2025 | −28.8% |
| 22 Aug 2025 | −32.3% |
| 29 Aug 2025 | −33.8% |
| 5 Sep 2025 | −26.8% |
| 12 Sep 2025 | −28.8% |
| 19 Sep 2025 | −37.7% |
| 26 Sep 2025 | −35.6% |
| 3 Oct 2025 | −36.0% |
| 10 Oct 2025 | −38.6% |
| 17 Oct 2025 | −42.1% |
| 24 Oct 2025 | −48.1% |
| 31 Oct 2025 | −48.9% |
| 7 Nov 2025 | −30.9% |
| 14 Nov 2025 | −28.4% |
| 21 Nov 2025 | −13.9% |
| 28 Nov 2025 | −7.4% |
| 5 Dec 2025 | −5.2% |
| 12 Dec 2025 | −0.8% |
| 19 Dec 2025 | +12.9% |
| 26 Dec 2025 | +8.2% |
| 2 Jan 2026 | +8.2% |
| 9 Jan 2026 | −0.3% |
| 16 Jan 2026 | +0.1% |
| 23 Jan 2026 | +22.9% |
| 1 Feb 2026 | +36.4% |
| 6 Feb 2026 | +10.8% |
| 13 Feb 2026 | +21.1% |
| 20 Feb 2026 | +4.4% |
| 27 Feb 2026 | −11.8% |
| 6 Mar 2026 | −18.7% |
| 13 Mar 2026 | −11.4% |
| 20 Mar 2026 | +14.2% |
| 27 Mar 2026 | +2.7% |
| 17 Apr 2026 | −29.2% |
| 24 Apr 2026 | −24.9% |
| 30 Apr 2026 | −21.1% |
| 8 May 2026 | −31.2% |
| 15 May 2026 | −36.1% |
| 22 May 2026 | −28.3% |
| 29 May 2026 | −32.9% |
| 4 Jun 2026 | −31.8% |
| 5 Jun 2026 | −24.3% |
| 10 Jun 2026 | −15.7% |
| 12 Jun 2026 | −29.4% |
| 17 Jun 2026 | −45.1% |
| 19 Jun 2026 | −40.2% |
| 24 Jun 2026 | −2.9% |
| 25 Jun 2026 | −4.9% |
| 1 Jul 2026 | −8.9% |
| 3 Jul 2026 | −6.6% |
| 10 Jul 2026 | −3.8% |
| 17 Jul 2026 | −12.3% |
| 24 Jul 2026 | −10.6% |
| 31 Jul 2026 | −2.3% |
| 7 Aug 2026 | −10.2% |
| 14 Aug 2026 | −17.0% |
| 21 Aug 2026 | −11.1% |
| 28 Aug 2026 | −10.6% |
| 4 Sep 2026 | −6.5% |
| 11 Sep 2026 | −0.6% |
| 18 Sep 2026 | −0.7% |
| 25 Sep 2026 | +5.8% |
| 28 Sep 2026 | +5.6% |
| 1 Oct 2026 | +10.0% |
| 9 Oct 2026 | +12.1% |
| 16 Oct 2026 | +9.5% |
| 23 Oct 2026 | −0.2% |
| 30 Oct 2026 | −0.8% |
| 6 Nov 2026 | +15.5% |
| 8 Nov 2026 | +11.0% |
| 13 Nov 2026 | +7.1% |
| 20 Nov 2026 | +5.2% |
Over the last 3.9 years the share price moved +322% while the NIFTY 500 moved +58%, so it is ahead of the index over that whole period. The chart above shows the 13-week comparison for every week.
This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.
What changed at Asgard Alcobev this quarter?
Three changes stood out: number of shareholders up 254% in a year, best operating margin in 12 quarters and highest quarterly profit in 13 quarters.
Number of shareholders up 254% in a year
5,485 shareholders in the September 2026 quarter, against 1,551 a year earlier.
Best operating margin in 12 quarters
Operating margin was 15% in the September 2026 quarter, against 3.7% a year earlier.
Highest quarterly profit in 13 quarters
Profit of ₹3 crore in the September 2026 quarter is the highest of the last 13 quarters.
What are Asgard Alcobev's latest quarterly results?
For July to September 2026 (the quarter ended 30 September 2026), Asgard Alcobev reported revenue of ₹48.9 crore, up 102.9% from ₹24.1 crore a year earlier, and a profit of ₹2.54 crore, up 1,394.1% from ₹0.17 crore.
Asgard Alcobev results: July to September 2026 against a year earlier
| Measure | July to September 2026 | July to September 2025 | Change |
|---|---|---|---|
| Revenue | ₹48.9 crore | ₹24.1 crore | +102.9% |
| Profit | ₹2.54 crore | ₹0.17 crore | +1,394.1% |
| Earnings per share | ₹0.06 | ₹0.01 | +500.0% |
| Operating margin | 15.0% | 3.7% | +11.3 points |
The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).
From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.
What is the Asgard Alcobev share price history?
Asgard Alcobev closed at ₹35.39 on 20 November 2026, down 28.3% from ₹49.33 a year earlier (21 November 2025) and up 142.4% over three years. Its highest weekly close since December 2022 was ₹85.54 on 28 March 2025.
Asgard Alcobev share price: then and now
| When | Close | Change to 20 Nov 2026 |
|---|---|---|
| 1 week ago · 13 Nov 2026 | ₹35.23 | +0.5% |
| 1 month ago · 19 Oct 2026 | ₹31.97 | +10.7% |
| 6 months ago · 22 May 2026 | ₹33.58 | +5.4% |
| 1 year ago · 21 Nov 2025 | ₹49.33 | −28.3% |
| 3 years ago · 21 Dec 2023 | ₹14.60 | +142.4% |
| Earliest and lowest weekly close in our records · 23 Dec 2022 | ₹8.38 | +322.3% |
| Highest weekly close since December 2022 · 28 Mar 2025 | ₹85.54 | −58.6% |
| 52-week high (weekly close) · 20 Mar 2026 | ₹56.51 | −37.4% |
| 52-week low (weekly close) · 30 Oct 2026 | ₹28.37 | +24.7% |
Weekly closing prices. Each change is the move from that price to the 20 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.
141 weekly closes from 23 December 2022 to 20 November 2026.
What is the latest news on Asgard Alcobev?
20 Nov 2026: Asgard Alcobev closed at ₹35.39, up 0.5% on the week and up 10.7% on the month. Results for July to September 2026: Revenue up 102.9% and profit up 1,394.1% on a year earlier.
What dividend does Asgard Alcobev pay?
No. Asgard Alcobev Ltd paid out 0% of its profit as dividends in each of its last 3 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate (as of 20 November 2026).
What to watch in Asgard Alcobev's next results?
When Asgard Alcobev reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: Revenue against the same quarter a year earlier.
- Revenue against the same quarter a year earlier. In the Sep 2026 quarter, revenue was +102.9% on a year earlier, and the last four quarters averaged +81.7%.
- Whether the operating margin stays near 15.0%. It is 11.3 percentage points higher than four quarters earlier.
- Net profit against the same quarter a year earlier. In the Sep 2026 quarter, profit was +1,394.1% on a year earlier. It has grown on a year earlier for 2 quarters in a row.
- Whether cash from operations catches up with profit. Only 67% of the last 2 years' profit came in as cash from operations.
Which stock lists is Asgard Alcobev on?
Asgard Alcobev is on one of our India lists: Penny stocks.
Is Asgard Alcobev profitable?
Asgard Alcobev Ltd earned ₹2.5 Cr of net profit in the Sep 2026 quarter, +1,394.1% on the same quarter a year earlier. That is the 2nd quarter in a row of profit growth. Full-year FY26 profit was ₹1.0 Cr. The Sep 2026 quarter's profit is 5.2% of that quarter's revenue. The same quarter a year earlier earned ₹0.2 Cr.
Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.
2 of the last 12 reported quarters were loss-making.
For the full year, FY26 profit was ₹1.0 Cr (−50.0% on the year before).
Why profit moved: revenue changed +102.9% on a year earlier and the margin moved +11.3 percentage points. Most of the change came from keeping more of each sale.
On average over the last four quarters, profit changed +355.8% and revenue +81.7%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.
How much revenue does Asgard Alcobev make, and is it growing?
Asgard Alcobev Ltd reported ₹48.9 Cr of revenue in the Sep 2026 quarter, +102.9% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. The last full year, FY26, came in at ₹101 Cr. The last four reported quarters add to ₹158 Cr.
Revenue is everything the company billed its customers in the period.
A growth rate over several years is not shown, because there are too few years of figures to work one out properly.
FY26 revenue was ₹101 Cr, +74.1% on the year before.
Is growth speeding up? Revenue over the last 12 months grew +82.9%, against +204.2% a year over the last 8 quarters (rolling over); profit over the last 12 months grew +89.9%, against +600.0% a year (rolling over).
How much of every ₹100 of sales does Asgard Alcobev keep?
Asgard Alcobev Ltd's operating margin was 15.0% in the Sep 2026 quarter, 11.3 percentage points higher than the same quarter a year ago. Across 3 years it has been between −5.0% and 8.6%. The latest quarter is above every full year in that period.
Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.
Why the margin moved: operating margin changed +11.3 percentage points on the year while gross margin changed +51.0 points. So the gain came mostly from the gross margin, which means input costs and prices charged.
Is Asgard Alcobev's profit turning into cash?
Over the last 2 years, 67% of Asgard Alcobev Ltd's reported profit came in as cash from its operations, so most of the profit is real cash. In FY26 it brought in ₹4.0 Cr of operating cash against ₹1.0 Cr of profit.
The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.
After ₹76.0 Cr of estimated spending on assets (worked out from the change in fixed assets plus depreciation; no filed figure), free cash was −₹72.0 Cr: it spent more than its operations brought in.
Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.
Why 67% of profit came in as cash: the cash cycle got 133 days shorter between FY24 and FY26, so cash that used to wait in the business now arrives sooner. When less than 70% of profit comes in as cash, it is the thing to watch on this page.
What to look at next: the bigger use of cash is spending on new assets, at 31.3× depreciation over three years. The next section checks what that spending is building.
Where does Asgard Alcobev's cash go?
Asgard Alcobev Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 35 days in FY26, down from 168 days in FY24. It spent ₹94.0 Cr on assets over the last 2 years. Customers take 126 days to pay, and stock sits for 116 days on average.
Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.
At FY26 sales of ₹101 Cr, each day of that cycle ties up about ₹0.3 Cr, so roughly ₹10.0 Cr is tied up in the business at any time.
FY26: customers took 126 days to pay and stock sat for 116 days, about 3.8 months of sales sitting as stock, for a full cycle of 35 days, shorter than FY24's 168.
The full loop: cash goes out to suppliers and production on day 0. Stock sits for 116 days. Customers pay about 126 days after that. Suppliers are paid at 207 days. Together that makes the 35-day cycle.
Spending on assets: ₹94.0 Cr over the last 2 years, against ₹3.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹0.0 Cr (FY26): assets paid for that are not earning yet.
In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.
What is Asgard Alcobev's P/E ratio, and how does it compare with its own history?
Asgard Alcobev Ltd's P/E is 294.9×, in the middle of its own history: higher than 45% of past readings. Its usual P/E (the middle reading) is 321.3×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.
P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.
Why the multiple is where it is: over the past year earnings per share moved −40.0% while the price moved −28.3%. The price did better than earnings, which pushed the multiple up within its own range.
In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple.
Is the Asgard Alcobev business getting better or worse?
Asgard Alcobev Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 7 quarters of 1 measure, with some gaps.
Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.
Why it matters: with too little history, we say so rather than guess a direction.
One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result.
The return figures here are yearly, not quarterly. They show level and direction only; they can support the growth lines but never decide the reading alone.
There are fewer than eight usable quarters, so this page does not guess a direction from so little history.
Compound annual growth rate (%)
Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.
| Measure | 1yr | 3yr | 5yr | 10yr |
|---|---|---|---|---|
| Revenue | +74.1% | — | — | — |
| Profit | −50.0% | — | — | — |
| EPS | −25.0% | — | — | — |
| Share price | −28.3% | — | — | — |
How much does Asgard Alcobev earn on its capital?
Asgard Alcobev Ltd earned a ROCE of 7% in FY26. Its return on capital used (ROIC) is 6.1 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 1.0% net margin and 0.50× asset turnover (sales divided by assets).
Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.
Why the return is what it is (FY26): a 1.0% net margin × 0.50× asset turnover × 4.49× leverage (assets divided by equity) ≈ 2.2% on equity. The margin does its share; borrowing is a big part of it.
The key test, return on capital used minus the cost of capital: 5.9% − 12.0% = −6.1 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.
Does Asgard Alcobev have too much debt?
Asgard Alcobev Ltd had ₹73.0 Cr of borrowings against ₹45.0 Cr of equity in FY26, so its debt is 1.62× its equity. Its operating profit is 4 times its interest bill. Over 2 years borrowings went from ₹0.0 Cr to ₹73.0 Cr. Over the last 2 of those years it spent ₹94.0 Cr on assets.
Debt-to-equity shows how much of the business is paid for with borrowed money. Interest cover shows how many times operating profit pays the interest bill. Low debt and high cover are the safe combination.
Part of the spending on assets is being paid for with borrowed money.
What is the Asgard Alcobev shareholding pattern?
Promoters cut their stake in Asgard Alcobev Ltd by 11.1 percentage points over 8 quarters, the biggest change among its owners. Promoters now own 60.0% of the company. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.
Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.
Why the owners changed: promoters drove it (−11.1 points). They reduced their stake.
How far is Asgard Alcobev from balance-sheet trouble?
For Asgard Alcobev Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.
The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.
How does Asgard Alcobev rank in its industry?
45.7 out of 100, rank 11 of 16 in Alcoholic Beverages, with 65% of the evidence available.
Asgard Alcobev Ltd scores 45.7 out of 100 against the 16 companies it is compared with in Alcoholic Beverages, ranking 11. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer.
The four parts add up to the total exactly: 22.1 + 6.7 + 8.5 + 8.4 = 45.7. This is the same number shown on the industry page; it is worked out once for the whole group and read here.
What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.
Which companies is Asgard Alcobev compared with?
Asgard Alcobev ranks 11 of 16 Alcoholic Beverages companies on the 4-Factor Sector Score, with 45.7 out of 100.
- 1Radico Khaitan LtdRADICO · losing its lead · Most evidence points up · 100% evidence70.9out of 100
How the score adds up
Growth & earnings 31.0/35 · Revenue 15.8% · Profit 73.8% · Operating margin change 4 points · 100% evidenceCapital efficiency 21.8/25 · ROCE 24.2% (year to Mar 2026) · Operating margin 20.5% · 100% evidenceValuation 6.0/20 · P/E 78.5× · PEG 2.6 · 100% evidenceRelative strength 12.1/20 · Strength vs its industry (price vs its 52-week average, weekly) 29.1% · Strength vs NIFTY 500 (same reading) 23.5% · 1 year 42.5% · 100% evidence · 9 of 12 weeks aheadExact sum: 31 + 21.8 + 6 + 12.1 = 70.9 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. - 2India Glycols LtdINDIAGLYCO · leader · Most evidence points up · 86% evidence65.9out of 100
How the score adds up
Growth & earnings 22.8/35 · Revenue 12% · Profit 29.9% · Operating margin change 1 points · 88% evidenceCapital efficiency 14.8/25 · ROCE 12.4% (year to Mar 2026) · Operating margin 15% · 100% evidenceValuation 8.3/20 · P/E 5.5× · PEG — · 50% evidenceRelative strength 20.0/20 · Strength vs its industry (price vs its 52-week average, weekly) 35.5% · Strength vs NIFTY 500 (same reading) 29.6% · 1 year 10.9% · 100% evidence · 12 of 12 weeks aheadExact sum: 22.8 + 14.8 + 8.3 + 20 = 65.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 3G M Breweries LtdGMBREW · quiet · Evidence leans up · 82% evidence55.9out of 100
How the score adds up
Growth & earnings 19.8/35 · Revenue 20.5% · Profit 21% · Operating margin change -2 points · 95% evidenceCapital efficiency 18.4/25 · ROCE 18% (year to Mar 2026) · Operating margin 23.4% · 76% evidenceValuation 12.6/20 · P/E 11.3× · PEG — · 50% evidenceRelative strength 5.1/20 · Strength vs its industry (price vs its 52-week average, weekly) -9% · Strength vs NIFTY 500 (same reading) -13.1% · 1 year -16.9% · 100% evidence · 1 of 12 weeks aheadExact sum: 19.8 + 18.4 + 12.6 + 5.1 = 55.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 4United Spirits LtdUNITDSPR · quiet · Evidence leans up · 100% evidence55.8out of 100
How the score adds up
Growth & earnings 16.9/35 · Revenue 1.1% · Profit 12.9% · Operating margin change -1 points · 100% evidenceCapital efficiency 22.0/25 · ROCE 26.4% (year to Mar 2026) · Operating margin 19.7% · 100% evidenceValuation 7.1/20 · P/E 57.7× · PEG 6.46 · 100% evidenceRelative strength 9.8/20 · Strength vs its industry (price vs its 52-week average, weekly) 4.2% · Strength vs NIFTY 500 (same reading) -0.4% · 1 year 2.8% · 100% evidence · 5 of 12 weeks aheadExact sum: 16.9 + 22 + 7.1 + 9.8 = 55.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 5IFB Agro Industries LtdIFBAGRO · basing · Evidence leans up · 68% evidence54.8out of 100
How the score adds up
Growth & earnings 20.7/35 · Revenue 29.5% · Profit 17.3% · Operating margin change -1 points · 100% evidenceCapital efficiency 13.8/25 · ROCE 12.7% (year to Mar 2026) · Operating margin 8.2% · 100% evidenceValuation 10.8/20 · P/E 13.7× · PEG — · 15% evidenceRelative strength 9.5/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -5% · 1 year -34.6% · 25% evidence · 0 of 12 weeks aheadExact sum: 20.7 + 13.8 + 10.8 + 9.5 = 54.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 6Piccadily Agro Industries LtdPICCADIL · quiet · Evidence leans up · 68% evidence54.6out of 100
How the score adds up
Growth & earnings 18.9/35 · Revenue 28.2% · Profit 24.6% · Operating margin change -1 points · 100% evidenceCapital efficiency 16.9/25 · ROCE 18% (year to Mar 2026) · Operating margin 20.9% · 100% evidenceValuation 10.0/20 · P/E 38.7× · PEG — · 15% evidenceRelative strength 8.8/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -11% · 1 year -13.6% · 25% evidence · 2 of 12 weeks aheadExact sum: 18.9 + 16.9 + 10 + 8.8 = 54.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 7Allied Blenders & Distillers LtdABDL · breaking out · Evidence leans down · 93% evidence48.2out of 100
How the score adds up
Growth & earnings 10.5/35 · Revenue 8.6% · Profit -15.3% · Operating margin change -1 points · 100% evidenceCapital efficiency 14.4/25 · ROCE 18.4% (year to Mar 2026) · Operating margin 12.1% · 100% evidenceValuation 4.7/20 · P/E 97.3× · PEG 2.91 · 65% evidenceRelative strength 18.6/20 · Strength vs its industry (price vs its 52-week average, weekly) 30.6% · Strength vs NIFTY 500 (same reading) 24.8% · 1 year 22.1% · 100% evidence · 9 of 12 weeks aheadExact sum: 10.5 + 14.4 + 4.7 + 18.6 = 48.2 · What this means: Relative strength against the index is 24.8%, and revenue and profit growth are weak. - 8Globus Spirits LtdGLOBUSSPR · quiet · Evidence leans down · 83% evidence48.2out of 100
How the score adds up
Growth & earnings 25.0/35 · Revenue 10.8% · Profit 100% · Operating margin change -1 points · 100% evidenceCapital efficiency 11.3/25 · ROCE 11.2% (year to Mar 2026) · Operating margin 7.9% · 100% evidenceValuation 10.2/20 · P/E 24.9× · PEG — · 15% evidenceRelative strength 1.7/20 · Strength vs its industry (price vs its 52-week average, weekly) -18.1% · Strength vs NIFTY 500 (same reading) -21.8% · 1 year -28.2% · 100% evidence · 0 of 12 weeks aheadExact sum: 25 + 11.3 + 10.2 + 1.7 = 48.2 · What this means: Earnings are strong; relative strength in its sector is -18.1% and the one-year return is -28.2%. - 9Jagatjit Industries LtdJAGAJITIND · quiet · Too little evidence to rank firmly · 52% evidence48.1out of 100
How the score adds up
Growth & earnings 22.6/35 · Revenue 5.9% · Profit 100% · Operating margin change 25.7 points · 71% evidenceCapital efficiency 6.0/25 · ROCE 10.5% (year to Mar 2026) · Operating margin 3.5% · 76% evidenceValuation 10.5/20 · P/E 16.3× · PEG — · 15% evidenceRelative strength 9.0/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -10.3% · 1 year -27.6% · 25% evidence · 8 of 12 weeks aheadExact sum: 22.6 + 6 + 10.5 + 9 = 48.1 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. - 10Associated Alcohols & Breweries LtdASALCBR · basing · Evidence leans down · 85% evidence46.7out of 100
How the score adds up
Growth & earnings 6.1/35 · Revenue -3.5% · Profit -11% · Operating margin change -2.9 points · 100% evidenceCapital efficiency 14.5/25 · ROCE 18% (year to Mar 2026) · Operating margin 6.5% · 100% evidenceValuation 18.6/20 · P/E 13.7× · PEG 1 · 100% evidenceRelative strength 7.5/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -30.7% · 1 year -44.4% · 25% evidence · 0 of 12 weeks aheadExact sum: 6.1 + 14.5 + 18.6 + 7.5 = 46.7 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. - 11Asgard Alcobev Ltd this pageturning · Evidence leans down · 65% evidence45.7out of 100
How the score adds up
Growth & earnings 22.1/35 · Revenue 68.3% · Profit 33.1% · Operating margin change 11.3 points · 95% evidenceCapital efficiency 6.7/25 · ROCE 7.4% (year to Mar 2026) · Operating margin 15% · 95% evidenceValuation 8.5/20 · P/E 294.9× · PEG — · 15% evidenceRelative strength 8.4/20 · Strength vs its industry (price vs its 52-week average, weekly) — · Strength vs NIFTY 500 (same reading) -14.6% · 1 year -28.3% · 25% evidence · 6 of 12 weeks aheadExact sum: 22.1 + 6.7 + 8.5 + 8.4 = 45.7 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. - 12United Breweries LtdUBL · quiet · Evidence leans down · 93% evidence44.5out of 100
- 13Sula Vineyards LtdSULA · quiet · Evidence leans down · 85% evidence43.0out of 100
- 14Tilaknagar Industries LtdTI · losing its lead · Evidence leans down · 87% evidence40.6out of 100
- 15Fratelli Vineyards Ltdturning · Too little evidence to rank firmly · 54% evidence32.2out of 100
- 16Som Distilleries & Breweries LtdSDBL · losing its lead · Most evidence points down · 72% evidence29.2out of 100
Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.
In this ranking every company's P/E uses its own latest official close and its last four filed quarters, the same rule as the top of this page. ROCE here is each company's last full year, as labelled, so it can differ from the four-quarter ROCE above. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.
Related companies: Alcoholic Beverages, all 16 compared on one page.
Which companies are close to Asgard Alcobev in size?
Asgard Alcobev is the 12th largest of 16 Alcoholic Beverages companies on Sector Alpha by market value (at the 20 November 2026 close). Just above it: India Glycols, Som Distilleries & Breweries and Sula Vineyards. Just below it: Associated Alcohols & Breweries, IFB Agro Industries and Jagatjit Industries.
Alcoholic Beverages companies close in size
- India Glycols Ltd ₹1,772 crore
- Som Distilleries & Breweries Ltd ₹1,563 crore
- Sula Vineyards Ltd ₹1,176 crore
- Asgard Alcobev Ltd ₹1,103 crore
- Associated Alcohols & Breweries Ltd ₹1,068 crore
- IFB Agro Industries Ltd ₹853 crore
- Jagatjit Industries Ltd ₹578 crore
All 16 Alcoholic Beverages companies, largest first
Companies close in size in other industries
- Bafna Pharmaceuticals Ltd ₹1,111 crore · Pharma - Formulators
- Wonder Electricals Ltd ₹1,111 crore · Consumer Electronics
- Asgard Alcobev Ltd ₹1,103 crore
- GPT Healthcare Ltd ₹1,099 crore · Hospitals
- Fedders Holding Ltd ₹1,098 crore · Finance & Investments - Others
What else do people ask about Asgard Alcobev?
What is Asgard Alcobev's share price today?
Asgard Alcobev Ltd's share price is ₹35.39, −28.3% over the past year. The whole company is worth ₹1,104 Cr on the market.
In the last 52 weeks it traded between ₹28 to ₹57; today it is 25% of the way up from the low, 5.1% below its 200-day average (as of 20 November 2026).
What were Asgard Alcobev's latest quarterly results?
Asgard Alcobev Ltd reported revenue of ₹48.9 Cr and net profit of ₹2.5 Cr for the Sep 2026 quarter. Revenue rose 102.9% and profit rose 1,394.1% compared with a year earlier. Earnings per share were ₹0.06.
The operating margin was 15.0%, 11.3 percentage points higher than a year earlier (as of 20 November 2026).
What is Asgard Alcobev's market cap?
Asgard Alcobev Ltd's market capitalisation is ₹1,104 Cr at a share price of ₹35.39. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 20 November 2026).
How is Asgard Alcobev performing?
Asgard Alcobev Ltd's share price has been falling for 62 weeks. In its latest quarter, revenue rose 102.9% and profit rose 1,394.1% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 4 weeks running (as of 20 November 2026).
Will Asgard Alcobev's share price go up?
This page does not forecast Asgard Alcobev Ltd's share price. What it shows instead: the share price is ₹35.39, and it has been falling for 62 weeks. Its P/E of 294.9× is higher than 45% of its own last 2 years (as of 20 November 2026).
Where is Asgard Alcobev in its business cycle?
Asgard Alcobev Ltd's FY26 operating margin was 6.9%, against a 3-year range of −5.0% to 8.6%. The latest quarter was 15.0%, above the top of its own yearly range in the latest quarter, so margins are at a high and the story depends on them staying there.
Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 20 November 2026).
What could break the Asgard Alcobev story?
The main question: promoters moved −11.1 percentage points over 8 quarters while the business went the other way. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 20 November 2026).
Is Asgard Alcobev a stock worth studying right now?
What the numbers show: Asgard Alcobev Ltd's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether the owners’ moves turn back in line with the business.
Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 20 November 2026).
Where do these numbers come from?
Sector Alpha, written by code from the published numbers. Data as of 20 November 2026.
Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.
See the plain-text version of this page.
More lists
Every Sector Alpha list, grouped
Stock screens
Market lists
Themes
Sectors
X · Instagram · YouTube · About · Newsletter · Newsletter archive
This is research, not advice. We’re not SEBI-registered.